Adenocarcinoma
1 competing product in clinical development for Adenocarcinoma.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ramucirumab (IMC-1121B ) + Paclitaxel | Eli Lilly | Phase 1 | Completed | 33 |
1 competing product in clinical development for Adenocarcinoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ramucirumab (IMC-1121B ) + Paclitaxel | Eli Lilly | Phase 1 | Completed | 33 |